LKFT LAKEFRONT BIOTHERAPEUTICS NV More: the full row for LAKEFRONT BIOTHERAPEUTICS NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,025,000 shares; 2025Q1: 1,314,898 shares; 2025Q2: 1,773,649 shares; 2025Q3: 1,150,000 shares; 2025Q4: 1,074,112 shares; 2026Q1: 1,550,000 shares; 2026Q2: 2,043,344 shares; 2026Q3: 1,998,400 shares 1,998,400 $59.3M 11.49% -44,944 Timeline STTK SHATTUCK LABS INC More: the full row for SHATTUCK LABS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,638,935 shares; 2025Q1: 6,638,935 shares; 2025Q2: 6,638,935 shares; 2025Q3: 5,451,195 shares; 2025Q4: 2,381,502 shares; 2026Q1: 5,004,439 shares; 2026Q2: 5,957,877 shares; 2026Q3: 7,648,094 shares 7,648,094 $52.2M 10.12% +1,690,217 Timeline JANX JANUX THERAPEUTICS INC More: the full row for JANUX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 329,768 shares; 2025Q1: 689,901 shares; 2025Q2: 853,904 shares; 2025Q3: 865,350 shares; 2025Q4: 2,392,523 shares; 2026Q1: 3,550,000 shares; 2026Q2: 3,804,481 shares; 2026Q3: 2,943,200 shares 2,943,200 $50.9M 9.87% -861,281 2026-11-10, 13G/A : 3,150,450 shares, 5.15% of the class, 13G/A filed 2026-11-13 Timeline NKTR NEKTAR THERAPEUTICS More: the full row for NEKTAR THERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 554,633 shares; 2026Q1: 735,000 shares; 2026Q2: 810,000 shares; 2026Q3: 785,000 shares 785,000 $47.5M 9.22% -25,000 Timeline ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 17,000 shares; 2026Q1: 105,000 shares; 2026Q2: 107,394 shares; 2026Q3: 376,794 shares 376,794 $37.3M 7.24% +269,400 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 375,609 shares; 2026Q3: 238,088 shares 238,088 $27.2M 5.27% -137,521 Timeline BSX BOSTON SCIENTIFIC CORP More: the full row for BOSTON SCIENTIFIC CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 76,100 shares; 2025Q4: 210,000 shares; 2026Q1: 795,547 shares; 2026Q2: 1,270,273 shares; 2026Q3: 550,000 shares 550,000 $24M 4.66% -720,273 Timeline IRTC IRHYTHM HOLDINGS INC More: the full row for IRHYTHM HOLDINGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 10,000 shares; 2026Q2: 165,500 shares; 2026Q3: 200,980 shares 200,980 $22.8M 4.43% +35,480 Timeline ALKS ALKERMES PLC More: the full row for ALKERMES PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 513,632 shares; 2026Q2: 394,389 shares; 2026Q3: 550,000 shares 550,000 $22.3M 4.32% +155,611 Timeline PRVA PRIVIA HEALTH GROUP INC More: the full row for PRIVIA HEALTH GROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,049,752 shares 1,049,752 $20.7M 4.01% new Timeline MLYS MINERALYS THERAPEUTICS INC More: the full row for MINERALYS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 449,795 shares; 2026Q3: 800,000 shares 800,000 $20.1M 3.9% +350,205 Timeline ZYME ZYMEWORKS INC More: the full row for ZYMEWORKS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 820,000 shares; 2025Q1: 957,229 shares; 2025Q2: 1,309,904 shares; 2025Q3: 749,611 shares; 2025Q4: 530,393 shares; 2026Q1: 539,049 shares; 2026Q2: 674,434 shares; 2026Q3: 721,100 shares 721,100 $19.1M 3.71% +46,666 Timeline SNDX SYNDAX PHARMACEUTICALS INC More: the full row for SYNDAX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 620,000 shares; 2025Q1: 609,252 shares; 2025Q2: 1,079,673 shares; 2025Q3: 1,003,400 shares; 2025Q4: 665,000 shares; 2026Q1: 770,000 shares; 2026Q2: 1,200,000 shares; 2026Q3: 812,582 shares 812,582 $15.3M 2.96% -387,418 Timeline KURA KURA ONCOLOGY INC More: the full row for KURA ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,325,000 shares; 2025Q1: 2,078,315 shares; 2025Q2: 3,181,184 shares; 2025Q3: 2,758,516 shares; 2025Q4: 2,529,600 shares; 2026Q1: 3,356,700 shares; 2026Q2: 2,021,964 shares; 2026Q3: 1,275,000 shares 1,275,000 $13.7M 2.65% -746,964 Timeline DNLI DENALI THERAPEUTICS INC More: the full row for DENALI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 550,700 shares 550,700 $11.4M 2.21% new Timeline PRAX PRAXIS PRECISION MEDICINES I More: the full row for PRAXIS PRECISION MEDICINES I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 36,400 shares 36,400 $10.6M 2.06% new Timeline HQY HEALTHEQUITY INC More: the full row for HEALTHEQUITY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 115,796 shares 115,796 $10.2M 1.99% new Timeline BBIO BRIDGEBIO PHARMA INC More: the full row for BRIDGEBIO PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 995,000 shares; 2025Q1: 610,000 shares; 2025Q2: 472,687 shares; 2025Q3: 264,500 shares; 2025Q4: 30,000 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 150,000 shares 150,000 $9.87M 1.91% new Timeline ALNY ALNYLAM PHARMACEUTICALS INC More: the full row for ALNYLAM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 17,109 shares; 2026Q1: 76,000 shares; 2026Q2: 98,080 shares; 2026Q3: 37,000 shares 37,000 $9.13M 1.77% -61,080 Timeline HUM HUMANA INC More: the full row for HUMANA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 22,000 shares 22,000 $8.39M 1.63% new Timeline ENOV ENOVIS CORPORATION More: the full row for ENOVIS CORPORATION Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 267,432 shares 267,432 $4.89M 0.95% new Timeline OKUR ONKURE THERAPEUTICS INC More: the full row for ONKURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 63,754 shares; 2025Q1: 186,570 shares; 2025Q2: 159,692 shares; 2025Q3: 267,959 shares; 2025Q4: 816,909 shares; 2026Q1: 2,154,381 shares; 2026Q2: 978,992 shares; 2026Q3: 1,325,570 shares 1,325,570 $3.61M 0.7% +346,578 Timeline QTRX QUANTERIX CORP More: the full row for QUANTERIX CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 825,000 shares 825,000 $3.06M 0.59% new Timeline GENB GENERATE BIOMEDICINES INC More: the full row for GENERATE BIOMEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 144,756 shares 144,756 $2.17M 0.42% new Timeline ANTX AN2 THERAPEUTICS INC More: the full row for AN2 THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 515,754 shares; 2026Q2: 474,638 shares; 2026Q3: 350,877 shares 350,877 $1.87M 0.36% -123,761 Timeline PLRX PLIANT THERAPEUTICS INC More: the full row for PLIANT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 334,263 shares; 2025Q2: 837,400 shares; 2025Q3: 20,487 shares; 2025Q4: 1,555,744 shares; 2026Q1: 1,667,600 shares; 2026Q2: 1,370,233 shares; 2026Q3: 1,604,466 shares 1,604,466 $1.73M 0.34% +234,233 Timeline RCKT ROCKET PHARMACEUTICALS INC More: the full row for ROCKET PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,088,706 shares; 2025Q1: 1,480,000 shares; 2025Q2: 1,580,588 shares; 2025Q3: 1,267,965 shares; 2025Q4: 743,942 shares; 2026Q1: 683,856 shares; 2026Q2: 700,000 shares; 2026Q3: 595,024 shares 595,024 $1.56M 0.3% -104,976 Timeline RNTX REIN THERAPEUTICS INC More: the full row for REIN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 404,979 shares; 2025Q1: 430,000 shares; 2025Q2: 427,919 shares; 2025Q3: 567,898 shares; 2025Q4: 442,600 shares; 2026Q1: 411,600 shares; 2026Q2: 1,100,000 shares; 2026Q3: 1,660,197 shares 1,660,197 $1.33M 0.26% +560,197 Timeline COYA COYA THERAPEUTICS INC More: the full row for COYA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 420,360 shares; 2026Q2: 170,000 shares; 2026Q3: 229,600 shares 229,600 $1.15M 0.22% +59,600 Timeline CRBP CORBUS PHARMACEUTICALS HLDGS More: the full row for CORBUS PHARMACEUTICALS HLDGS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 270,000 shares; 2025Q1: 575,136 shares; 2025Q2: 579,893 shares; 2025Q3: 343,400 shares; 2025Q4: 683,872 shares; 2026Q1: 697,108 shares; 2026Q2: 650,000 shares; 2026Q3: 168,383 shares 168,383 $1.15M 0.22% -481,617 Timeline IMRX IMMUNEERING CORP More: the full row for IMMUNEERING CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 123,409 shares; 2026Q2: 36,861 shares; 2026Q3: 150,000 shares 150,000 $614K 0.12% +113,139 Timeline ADCT ADC THERAPEUTICS SA More: the full row for ADC THERAPEUTICS SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,515,000 shares; 2025Q1: 9,543,004 shares; 2025Q2: 10,467,771 shares; 2025Q3: 7,472,303 shares; 2025Q4: 8,477,338 shares; 2026Q1: 8,300,000 shares; 2026Q2: 7,824,749 shares; 2026Q3: 399,900 shares 399,900 $488K 0.09% -7,424,849 Timeline